Mie University · Advanced Reproductive Medicine Center

Research keywords胎児発育不全・周産期管理・タダラフィル治療・胎盤酸素化MRI・妊娠中COVID-19・子宮動脈血流評価・分娩誘発・子宮体癌腹腔鏡手術

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Reference range for C1-esterase inhibitor (C1 INH) in the third trimester of pregnancy.
• Clinical Characteristics of the Controlled-Release Dinoprostone Vaginal Delivery System (PROPESS).
• In utero spontaneous bladder rupture in a fetus with posterior urethral valve: A case report of prenatal diagnosis and management.
• Safety and dose-finding trial of tadalafil administered for fetal growth restriction: A phase-1 clinical study.

• 胎児発育不全治療薬のタダラフィルが胎児新生児循環に与える影響の解析
• ホスホジエステラーゼ5阻害薬：タダラフィル投与による胎児発育改善のメカニズム解明
• 分娩時の母体呼吸および循環パラメータ変化の評価と助産介入による児の予後改善
• 胎児発育不全に対するタダラフィル投与の安全性に関する分子基盤の確立

• Official profile